C Napoli, V Sica, F De Nigris, O Pignalosa, M … - American Heart Journal, 2004 - Elsevier Plasma LDL oxidizability was investigated initially in untreated
normocholesterolemic patients with moderate essential hypertension without
clinically evident target organ damage (n = 96) and in control normotensive ... Cited by 86 - Related articles - All 8 versions
C Borghi, S Bacchelli, D Degli Esposti, E … - eop, 2004 - informahealthcare.com Based on preclinical and clinical findings, zofenopril appears to be an angio-
tensin-converting enzyme (ACE) inhibitor with high potency, significant tis- sue
selectivity and a long duration of action. Its ancillary properties, such ... Cited by 20 - Related articles - All 4 versions
C Borghi, E Ambrosioni - American Heart Journal, 2007 - Elsevier The primary end point occurred in 20.3% of zofenopril-treated and 35.9% of
placebo-treated patients (P = .001), despite no differences in blood pressure
control, LVF, and concomitant therapy. ST-T depression during ambulatory ... Cited by 6 - Related articles - All 3 versions
G Parati, S Omboni, E Malacco - Blood Pressure, 2006 - informahealthcare.com Objective. The effects of a 12‐week double‐blind randomized treatment with
zofenopril (Z) 15, 30 or 60 mg or hydrochlorothiazide (HCTZ) 12.5 or 25 mg, on
trough office (n = 353) and 24‐h blood pressure (BP, n = 245) were ... Cited by 7 - Related articles - BL Direct - All 5 versions
AL Abbate - Pharmacological Reports, 2005 - if-pan.krakow.pl Abstract: Diabetes, with hyperglycemia as its hallmark, is a major risk factor
for ischemic heart disease. The role of coronary disease in the adverse
prognosis of diabetes is controversial although the higher prevalence and ... Cited by 6 - Related articles - View as HTML - BL Direct - All 9 versions
G Leonetti, A Rappelli, S Omboni - Blood Pressure, 2006 - informahealthcare.com Objective. To compare the antihypertensive effect of treatment with zofenopril
vs candesartan by office and ambulatory blood pressure (BP). Design and methods.
Following a 2‐week wash‐out from previous treatment, 236 grade I–II ... Cited by 5 - Related articles - BL Direct - All 5 versions
E Malacco, S Omboni - Advances in Therapy, 2007 - Springer This study was undertaken to compare the antihypertensive efficacy of zofeno-
pril 30 mg + hydrochlorothiazide 12.5 mg fixed combination versus zofenopril
alone in patients with essential hypertension with and without the ... Cited by 4 - Related articles - BL Direct - All 2 versions
C Borghi, AFG Cicero, E Ambrosioni - Vascular health and risk management, 2008 - pubmedcentral.nih.gov Of the 1418 patients included in this post-hoc analysis, 686 (48.3%) had MS.
After 6 weeks of treatment zofenopril significantly reduced the incidence of
all-cause death and severe congestive failure (risk reduction: 69%, 95% CI: ... Cited by 2 - Related articles - All 9 versions
S Feit, 2006 - unitedhealthfoundation.org Disclaimer: The information contained in this publication is intended for
medical professionals. We rely on studies to confirm the accuracy of the
information presented, and to describe generally accepted practices, and ... Cited by 1 - Related articles - View as HTML
АВ Добровольский, АЛ Сыркин - Рус. мед. журн, 2006 - w.rmj.ru Введение Ингибиторы
ангиотензинпревращающего фермента (АПФ) в
настоящее время являются одними из ... Cited by 1 - Related articles - Cached - All 16 versions
